Winner
GAOMA Therapeutics
GHP News Excellence Award for Research and Innovation
International Life Sciences Awards - 2021
GAOMA Therapeutics
International Life Sciences Awards - 2021
GAOMA Therapeutics is a French biotech company founded in 2019, with the ambition to develop lipids derivatives as innovative drug-candidates.
The company’s first lead molecule, GAO-3-02, aims to address epilepsy and cognitive disorders by targeting neuroinflammation and brain plasticity.